Access cutting-edge inflammatory bowel disease (ibd) treatment through this clinical trial at a research site in New Orleans. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this New Orleans location
Preparing your pre-screening questions…
Access inflammatory bowel disease (ibd) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related inflammatory bowel disease (ibd) treatment provided free
Check if you qualify for this inflammatory bowel disease (ibd) clinical trial in New Orleans, LA
No-Cost Study Care
Local to New Orleans
Convenient for LA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this observational study is to assess the feasibility and effectiveness of a remote monitoring digital health system on adherence, clinical outcomes, and healthcare utilization in patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis, and inflammatory bowel disease type undetermined) initiating therapy with vedolizumab (Entvyio). The main questions it aims to answer are: 1. Assess and compare adherence to intravenous (IV) and subcutaneous vedolizumab maintenance therapy in patients with IBD using a novel remote monitoring system. 2. Assess symptom response to vedolizumab post induction (week 6-8) and during maintenance therapy (week 22) using a novel remote monitoring system. 3. Assess time to response to vedolizumab during induction (weeks 0-6) using a novel remote monitoring system. Researchers will compare medication adherence between participants using IV and subcutaneous vedolizumab maintenance therapy to see if adherence is lower with self-administration. Participants will be asked to register adherence to medication using the novel remote monitoring system each time they take a dose of vedolizumab and to respond to two questions about bowel symptoms weekly for the first 6 weeks after starting vedolizumab then monthly thereafter for 6 months. Additionally, participants will be asked to enter information regarding demographics and social determinants of health at baseline and other variables listed below at baseline and at weeks 2, 6, 14, and 22 post baseline unless otherwise denoted: * MARS-5 * Healthcare utilization (22 weeks only) * Harvey Bradshaw Index (Crohn's disease only) * Simple clinical colitis activity index (Ulcerative colitis only) * PROMIS Global Health Scale * PROMIS Anxiety * PROMIS Depression * PROMIS Sleep Disturbance * PROMIS Pain Interference * PROMIS Physical Function * IBD Self-Efficacy * Attitudinal Survey (22 weeks only)
Sponsor: Mercy Medical Center
Yes, this clinical trial (NCT06750731) has an active research site in New Orleans, LA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for inflammatory bowel disease (ibd) treatment options in New Orleans, LA, this clinical trial (NCT06750731) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Orleans research site is actively enrolling participants for this clinical trial. You'll receive care from experienced inflammatory bowel disease (ibd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all inflammatory bowel disease (ibd) clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in New Orleans — not just this study.
Browse Multiple Myeloma Trials in New Orleans →